Bio-Rad's Q3 Results: Some Good News and Some Bad News
Bio-Rad Laboratories (NYSE: BIO) appears to be headed for its best stock performance so far in this decade. Its shares have soared 44% year to date, trouncing the returns of most healthcare stocks.
The company announced its third-quarter results after the market closed on Thursday. Bio-Rad gave investors some good news, but also some bad news. Here are the highlights from the company's Q3 update.
Image source: Getty Images.
Source Fool.com
